Pad Chivukula - Jan 4, 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Chief Scientific Officer & COO
Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Jan 4, 2022
Transactions value $
-$324,000
Form type
4
Date filed
1/6/2022, 03:01 PM
Previous filing
Dec 20, 2021
Next filing
Jun 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Sale -$324K -8.1K -1.34% $40.00 594K Jan 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.